SLG
GHDX

Stanley-Laman Group’s Genomic Health, Inc. GHDX Stock Holding History

Stanley-Laman Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-14,686
Closed -$408K – 374
2015
Q2 		$408K Sell
14,686
-48
-0.3% -$1.35K 0.07% 222
2015
Q1 		$450K Sell
14,734
-3,003
-17% -$95.5K 0.08% 221
2014
Q4 		$567K Hold
17,737
– – 0.11% 200
2014
Q3 		$502K Sell
17,737
-4,493
-20% -$125K 0.1% 199
2014
Q2 		$609K Sell
22,230
-871
-4% -$23.2K 0.11% 179
2014
Q1 		$608K Buy
+23,101
New +$663K 0.11% 182

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stanley-Laman Group's GHDX Position: Q3 2015 in Review

Stanley-Laman Group sold out of Genomic Health, Inc. (GHDX) in Q3 2015, closing a stake of 14,686 shares — an estimated $408K sold.

Stanley-Laman Group first reported a position in GHDX in Q1 2014 and held it in 6 quarters. The position peaked at $609K in Q2 2014. 117 funds tracked by Wall St. Rank hold GHDX as of Q3 2015.

  • Stanley-Laman Group reported no remaining Genomic Health, Inc. position as of Q3 2015 after selling out during the quarter.
  • Stanley-Laman Group sold 14,686 Genomic Health, Inc. shares in Q3 2015, an estimated $408K.
  • Stanley-Laman Group first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 6 quarters.
  • Stanley-Laman Group's Genomic Health, Inc. position peaked at $609K in Q2 2014.
  • 117 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2015.

Based on Stanley-Laman Group's 13F filing for Q3 2015, filed 3 Nov 2015.